BKV Corp CFO sells 7,300 shares in plan trade

BKV Corp’s Chief Financial Officer, David Tameron, reported an open-market sale of 7,300 shares of Common Stock on March 27, 2026 at a weighted average price of $29.7149 per share, with individual trade prices ranging from $29.46 to $29.8450.

Rhea-AI Filing Summary

BKV Corp’s Chief Financial Officer, David Tameron, reported an open-market sale of 7,300 shares of Common Stock on March 27, 2026 at a weighted average price of $29.7149 per share, with individual trade prices ranging from $29.46 to $29.8450.

The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 3, 20225. Following this sale, he holds 61,925 shares directly and an additional 300 shares indirectly through his son.

Insider Trade Summary 10b5-1

Net Seller: 7,300 shares

Net Sell 3 txns

Insider Tameron David

Role Chief Financial Officer

Sold 7,300 shs ($217K)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,300	$29.7149	$217K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 61,925 shares (Direct); Common Stock — 600 shares (Indirect, By Son)

Footnotes (2)

1. F1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 20225.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.46 to $29.8450, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BKV (BKV) report for its CFO?

BKV Corp’s Chief Financial Officer, David Tameron, reported an open-market sale of 7,300 shares of Common Stock. The transaction occurred on March 27, 2026 and was disclosed in a Form 4 insider trading report filed with regulators.

At what price did the BKV (BKV) CFO sell his shares?

The CFO’s 7,300-share sale was executed at a weighted average price of $29.7149 per share. Individual trades took place within a price range from $29.46 to $29.8450, as detailed in the accompanying Form 4 footnote.

How many BKV (BKV) shares does the CFO hold after the sale?

After the reported sale, the BKV Corp CFO holds 61,925 shares of Common Stock directly. The filing also shows an additional 300 shares held indirectly through his son, providing a view of his remaining equity exposure.

Was the BKV (BKV) CFO’s share sale under a Rule 10b5-1 plan?

Yes. The filing states the reported transaction was effected pursuant to a Rule 10b5-1 trading plan. That plan was adopted by the reporting person on December 3, 20225, indicating the sale followed a pre-established trading arrangement.

What is the net share effect of the BKV (BKV) CFO’s recent trade?

The transaction summary shows a net sale of 7,300 shares of BKV Corp Common Stock. There were no reported purchases, option exercises, gifts, or tax-withholding events in this filing, resulting in a net-sell direction for the reported period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tameron David

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER COLORADO 80202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/27/2026		S(1)		7,300	D	$29.7149(2)	61,925	D
Common Stock								300	I	By Son
Common Stock								300	I	By Son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 20225.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.46 to $29.8450, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)